Product Information

NYSTATIN-TRIAMCINOLONE OINTM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3155 per GM under NDC 45802024414. Its NADAC has been published 448 times since Nov 29, 2017.

NYSTATIN-TRIAMCINOLONE OINTM

nystatin and triamcinolone acetonide
$0.3155per GM

Strength

100000; 1 [USP'U]/g; mg/g

NDC

45802024414

Classification

Generic

Dosage Form

OINTMENT

Route

TOPICAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207380

On Market Since

10/18/2017

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid
Polyene Antifungal
Polyenes

Price Statistics

The NADAC for NYSTATIN-TRIAMCINOLONE OINTM has been published 448 times since Nov 29, 2017, and over the history we have for it it has declined 87.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3155 per GM
All-time high$3.2553 (Mar 14, 2018)
All-time low$0.2317 (May 22, 2024)
52-week high$0.3817
52-week low$0.3077
Median price$0.4287
Average price$0.6160
Largest weekly change+125.8% (Feb 21, 2018)
Weeks tracked448
Tracking sinceNov 29, 2017

Price History

1W

0.0%

1M

+2.5%

3M

+1.6%

6M

-13.4%

1Y

-8.3%

3Y

-10.2%

5Y

-45.5%

All

-87.0%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 29%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of NYSTATIN-TRIAMCINOLONE OINTM?

The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE OINTM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3155 per GM (NDC 45802024414), effective Jun 24, 2026.

How has the price of NYSTATIN-TRIAMCINOLONE OINTM changed over time?

Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE OINTM has declined 87.0%. It has been tracked across 448 weekly CMS publications since Nov 29, 2017.

What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE OINTM?

Since Nov 29, 2017, the NADAC for NYSTATIN-TRIAMCINOLONE OINTM has ranged from a low of $0.2317 (May 22, 2024) to a high of $3.2553 (Mar 14, 2018), with a median of $0.4287 per GM.

Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE OINTM?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, NYSTATIN-TRIAMCINOLONE OINTM, is $0.2244 per GM — about 29% below NYSTATIN-TRIAMCINOLONE OINTM.

Who manufactures NYSTATIN-TRIAMCINOLONE OINTM?

NYSTATIN-TRIAMCINOLONE OINTM (NDC 45802024414) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.